Engineered Stem Cell Membrane-Coated Nanodrugs for Targeted Therapy of Alzheimer’s Disease
ACS Applied Materials & Interfaces · 20.08.2025 · 17 (33) · 47497-47511
DOI: 10.1021/acsami.5c09843 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 06.08.2025. Verfasst von Shuang Sha und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Nanoparticles, Neural Stem Cells, Cell Membrane. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Basic and Applied Basic Research Foundation of Guangdong Province, Sanming Project of Medicine in Shenzen Municipality.
Themen: Demenz
Abstract (Originalsprache)
The pathological complexity of Alzheimer's disease (AD) necessitates the development of efficient nanomedicine delivery systems. Nanoparticles are considered promising therapeutic candidates for AD owing to their drug-loading capacity. This study introduces an engineered cell membrane coating strategy to enhance nanoparticle functionality in targeting efficiency and susceptivity to immune clearance. We developed an engineered biomimetic nanodrug delivery system by modifying nanoparticles with Gas6-overexpressing neural stem cell membranes for improving microglia targeting, pro-phagocytic properties and immunomodulatory effects, constructing a composite system designated as Gas6-NV-NPs. The system employs poly(lactic-co-glycolic acid) (PLGA) as a carrier to coencapsulate Rapamycin (RAP) and nicotinamide riboside (NR) (referred to as NPs), while leveraging Gas6 protein to specifically bind microglial surface receptors, enabling precise targeting of AD pathological regions. Our findings demonstrated that Gas6-NV-NPs restored lysosomal acidification in microglia, enhanced microglial phagocytic clearance of amyloid-β (Aβ), and reinstated the anti-inflammatory phenotype in BV2 microglial cells. Furthermore, Gas6-NV-NPs exhibited favorable biosafety and robust brain-targeting capability in vivo, effectively promoting Aβ clearance and neuronal repair in 5 × FAD mice model of AD. This "engineered membrane modification-nanodrug delivery" synergistic strategy enhances therapeutic targeting and achieves multitargeted effects, offering a approach to overcoming critical bottlenecks in AD nanotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, China.
- Daxing Research Institute, University of Science and Technology Beijing, Beijing 100083, China.
- Department of Traditional Chinese Medicine, South China Hospital, Medical School, Shenzhen University, Shenzhen 518116, P. R. China.
ORCID-Profile: Hongwu Du
Förderung
- National Key Research and Development Program of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Sanming Project of Medicine in Shenzen Municipality
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Beijing Science and Technology New Star Cross Project
Zitieren
APA
Sha, S., Sun, C., Gao, X., Bi, W., Chen, H., Ren, W., Wang, L., Luo, E., Xing, C., & Du, H. (2025). Engineered Stem Cell Membrane-Coated Nanodrugs for Targeted Therapy of Alzheimer’s Disease. ACS Applied Materials & Interfaces, 17(33), 47497-47511. https://doi.org/10.1021/acsami.5c09843
Vancouver
Sha S, Sun C, Gao X, Bi W, Chen H, Ren W, et al. Engineered Stem Cell Membrane-Coated Nanodrugs for Targeted Therapy of Alzheimer’s Disease. ACS Applied Materials & Interfaces. 2025;17(33):47497-47511. doi:10.1021/acsami.5c09843
BibTeX
@article{Sha2025,
author = {Sha, Shuang and Sun, Chunbin and Gao, Xiaoyu and Bi, Wangyu and Chen, Hongyu and Ren, Weijie and Wang, Lei and Luo, Enli and Xing, Cencan and Du, Hongwu},
title = {Engineered Stem Cell Membrane-Coated Nanodrugs for Targeted Therapy of Alzheimer’s Disease},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
volume = {17},
number = {33},
pages = {47497--47511},
doi = {10.1021/acsami.5c09843}
}
EUVIMED